ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $55,000 | -30.4% | 30,000 | 0.0% | 0.01% | -31.6% |
| Q2 2021 | $79,000 | -37.3% | 30,000 | -14.3% | 0.02% | -42.4% |
| Q1 2021 | $126,000 | -43.5% | 35,000 | -60.5% | 0.03% | -52.9% |
| Q4 2020 | $223,000 | -69.4% | 88,525 | -69.4% | 0.07% | -73.6% |
| Q3 2020 | $728,000 | -4.1% | 289,025 | +24.6% | 0.26% | -7.0% |
| Q2 2020 | $759,000 | +34.3% | 232,025 | +0.7% | 0.28% | +9.6% |
| Q1 2020 | $565,000 | -75.4% | 230,525 | -52.6% | 0.26% | -39.4% |
| Q4 2019 | $2,294,000 | +122.5% | 486,050 | +101.8% | 0.43% | -7.3% |
| Q3 2019 | $1,031,000 | -18.5% | 240,800 | +11.0% | 0.46% | -19.9% |
| Q2 2019 | $1,265,000 | +64.3% | 216,950 | +8.5% | 0.58% | +55.8% |
| Q1 2019 | $770,000 | +118.1% | 199,950 | +5.8% | 0.37% | +71.0% |
| Q4 2018 | $353,000 | – | 188,950 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |